Insider Transactions in Q3 2022 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
735
-2.3%
|
$13,965
$19.04 P/Share
|
|
Sep 19
2022
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
1,267
-0.44%
|
$24,073
$19.04 P/Share
|
|
Sep 19
2022
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,267
-1.99%
|
$24,073
$19.04 P/Share
|
|
Sep 19
2022
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
449
-1.48%
|
$8,531
$19.04 P/Share
|
|
Sep 01
2022
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+24.75%
|
-
|
|
Aug 11
2022
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.61%
|
$0
$0.49 P/Share
|
|
Aug 09
2022
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,336
+4.99%
|
$0
$0.49 P/Share
|
|
Jul 22
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
250,000
+16.99%
|
$5,000,000
$20.0 P/Share
|
|
Jul 22
2022
|
Lorence H. Kim |
BUY
Open market or private purchase
|
Direct |
50,000
+45.25%
|
$1,000,000
$20.0 P/Share
|
|
Jul 12
2022
|
Lorence H. Kim |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|